monarchE Profiling and ctDNA
monarchE: Molecular Profiling of Primary Tumor Tissue and ctDNA Detection in Patients With High-Risk, Node-Positive HR+/HER2- EBC Treated With Adjuvant ET ± Abemaciclib

Released: December 10, 2023

Activity

Progress
1
Course Completed